Back to Search Start Over

Life-Threatening Reaction with Topical 5-Fluorouracil.

Authors :
Kishi P
Price CJ
Source :
Drug safety - case reports [Drug Saf Case Rep] 2018 Jan 12; Vol. 5 (1), pp. 4. Date of Electronic Publication: 2018 Jan 12.
Publication Year :
2018

Abstract

A 67-year-old man developed a suspected adverse drug reaction during treatment with topical 5-fluorouracil (5-FU) for multiple actinic keratosis of the face, neck, and forearms. The man received topical 5-FU at a dosage of 0.5% for the actinic keratoses. After 1 week, he developed extreme lethargy, fatigue, fever, and mouth erosions. Several days later, and after discontinuation of 5-FU, painful mucositis and systemic side effects occurred, meeting criteria for hospitalization because of dehydration and a 6.8 kg weight loss. Hematology/oncology was consulted, and a possible systemic 5-FU reaction, similar to reactions to intravenous chemotherapy seen with a dihydropyrimidine dehydrogenase deficiency was suggested. The patient was not taking any concurrent medications, and he refused dihydropyrimidine dehydrogenase deficiency testing.

Details

Language :
English
ISSN :
2199-1162
Volume :
5
Issue :
1
Database :
MEDLINE
Journal :
Drug safety - case reports
Publication Type :
Academic Journal
Accession number :
29330682
Full Text :
https://doi.org/10.1007/s40800-017-0068-6